Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.55M Buy
213,000
+77,755
+57% +$3.3M 0.46% 52
2025
Q4
$4.89M Buy
135,245
+62,858
+87% +$2.57M 0.51% 51
2025
Q3
$3.57M Sell
72,387
-33,681
-32% -$1.37M 0.31% 72
2025
Q2
$3.34M Sell
106,068
-6,117
-5% -$138K 0.38% 50
2025
Q1
$2.02M Buy
112,185
+96,485
+615% +$2.41M 0.29% 59
2024
Q4
$540K Sell
15,700
-29,983
-66% -$781K 0.08% 169
2024
Q3
$1.02M Buy
45,683
+8,681
+23% +$142K 0.14% 94
2024
Q2
$515K Buy
37,002
+13,650
+58% +$195K 0.07% 139
2024
Q1
$348K Buy
+23,352
New +$301K 0.05% 229

Other funds holding IPX

Shay Capital's IPX Position: Q1 2026 in Review

Shay Capital increased its IperionX (IPX) stake by 57% in Q1 2026, buying an estimated $3.3M and bringing the position to 213,000 shares worth $5.55M. The position accounts for 0.46% of the portfolio, ranked #52.

Shay Capital first reported a position in IPX in Q1 2024 and has held it in 9 quarters since. 45 funds tracked by Wall St. Rank hold IPX as of Q1 2026.

  • Shay Capital held 213,000 shares of IperionX worth $5.55M as of Q1 2026.
  • Shay Capital bought 77,755 IperionX shares in Q1 2026, an estimated $3.3M.
  • IperionX made up 0.46% of Shay Capital's portfolio in Q1 2026, its #52 holding.
  • Shay Capital first reported a position in IperionX in Q1 2024 and has held it in 9 quarters since.
  • 45 funds tracked by Wall St. Rank held IperionX as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.